Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Benzhydryl Compounds | 4 | 2018 | 240 | 1.77 | Why? |
| Glucosides | 4 | 2018 | 359 | 1.62 | Why? |
| Diabetic Nephropathies | 6 | 2018 | 315 | 1.10 | Why? |
| Diabetes Mellitus, Type 2 | 15 | 2020 | 6166 | 0.90 | Why? |
| Albuminuria | 8 | 2018 | 164 | 0.69 | Why? |
| Hypoglycemic Agents | 5 | 2018 | 2165 | 0.69 | Why? |
| Membrane Transport Modulators | 1 | 2017 | 11 | 0.69 | Why? |
| Renal Insufficiency, Chronic | 7 | 2019 | 2654 | 0.64 | Why? |
| Blood Pressure | 6 | 2019 | 2198 | 0.42 | Why? |
| Sodium-Glucose Transporter 2 | 3 | 2017 | 111 | 0.36 | Why? |
| Glomerular Filtration Rate | 9 | 2020 | 1262 | 0.34 | Why? |
| Gastrectomy | 2 | 2018 | 225 | 0.32 | Why? |
| Hyperglycemia | 4 | 2020 | 1363 | 0.29 | Why? |
| Cardiovascular Diseases | 6 | 2020 | 11497 | 0.25 | Why? |
| Glycated Hemoglobin A | 4 | 2019 | 1316 | 0.24 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.19 | Why? |
| Drug Resistance | 2 | 2018 | 395 | 0.18 | Why? |
| Cholecalciferol | 1 | 2021 | 246 | 0.17 | Why? |
| Diabetes Complications | 2 | 2020 | 2358 | 0.17 | Why? |
| Uric Acid | 2 | 2017 | 285 | 0.17 | Why? |
| Obesity, Morbid | 2 | 2018 | 1340 | 0.16 | Why? |
| Diabetic Cardiomyopathies | 1 | 2017 | 79 | 0.15 | Why? |
| Hyperuricemia | 1 | 2017 | 160 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.14 | Why? |
| Fasting | 2 | 2017 | 555 | 0.14 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.14 | Why? |
| Diabetes Mellitus, Type 1 | 3 | 2018 | 1969 | 0.14 | Why? |
| Diabetic Angiopathies | 1 | 2017 | 146 | 0.14 | Why? |
| Smokers | 1 | 2020 | 550 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 2017 | 418 | 0.13 | Why? |
| Energy Metabolism | 1 | 2018 | 451 | 0.13 | Why? |
| Kidney | 2 | 2018 | 3648 | 0.13 | Why? |
| Hypertension | 4 | 2019 | 8895 | 0.13 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.13 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.12 | Why? |
| Kidney Failure, Chronic | 3 | 2019 | 3222 | 0.12 | Why? |
| Specimen Handling | 2 | 2020 | 6190 | 0.12 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.12 | Why? |
| Blood Glucose | 4 | 2020 | 3642 | 0.11 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.11 | Why? |
| Antihypertensive Agents | 3 | 2018 | 1962 | 0.11 | Why? |
| Triglycerides | 3 | 2018 | 478 | 0.11 | Why? |
| Long QT Syndrome | 1 | 2020 | 1047 | 0.10 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.09 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.08 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.08 | Why? |
| Disease Progression | 4 | 2018 | 13580 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.08 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.08 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.08 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.07 | Why? |
| Aged | 17 | 2021 | 215776 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Italy | 8 | 2020 | 38444 | 0.07 | Why? |
| Male | 22 | 2021 | 367725 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Blood Pressure Determination | 2 | 2019 | 450 | 0.07 | Why? |
| Female | 22 | 2021 | 380317 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Humans | 30 | 2021 | 930598 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.06 | Why? |
| Follow-Up Studies | 5 | 2018 | 17020 | 0.06 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.06 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Ribonuclease P | 1 | 2020 | 84 | 0.05 | Why? |
| Injections, Intravenous | 1 | 2021 | 381 | 0.05 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Calorimetry, Indirect | 1 | 2018 | 49 | 0.05 | Why? |
| Age of Onset | 1 | 2020 | 557 | 0.05 | Why? |
| Caloric Restriction | 1 | 2018 | 56 | 0.05 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Databases, Factual | 3 | 2017 | 6248 | 0.04 | Why? |
| Rest | 1 | 2018 | 188 | 0.04 | Why? |
| Glucose Tolerance Test | 1 | 2017 | 238 | 0.04 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Death, Sudden | 1 | 2017 | 160 | 0.04 | Why? |
| Adult | 8 | 2021 | 244371 | 0.04 | Why? |
| Death, Sudden, Cardiac | 1 | 2020 | 522 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Body Composition | 1 | 2018 | 414 | 0.03 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.03 | Why? |
| Body Weight | 1 | 2020 | 1074 | 0.03 | Why? |
| Cholesterol, HDL | 1 | 2017 | 439 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.03 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.03 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.03 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2017 | 791 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2019 | 1425 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2017 | 9893 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.03 | Why? |
| Temperature | 1 | 2020 | 2305 | 0.03 | Why? |
| Congresses as Topic | 1 | 2019 | 1347 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Laparoscopy | 1 | 2017 | 1532 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2018 | 3892 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 5277 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Fioretto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(199)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_